CoChat

Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Beta blockers have been shown to reduce morbidity and mortality in patients with heart failure without evidence of overt congestion. No data are available describing outcomes of patients admitted with exacerbated chronic heart failure who are receiving beta blockade at the time of admission. The purpose of this analysis was to evaluate clinical outcomes in patients from the Outcomes of the Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study who were prescribed beta blockers on admission compared with patients who were not prescribed beta blockers at admission. In all, 212 patients were treated with beta blockers at admission and 737 patients were not. Baseline characteristics were similar between groups, except that patients prescribed beta blockers on admission had slightly higher ejection fractions, fewer New York Heart Association class IV symptoms, and lower heart rates. There was no difference in clinical events between patients who were treated with beta blockers at the time of admission and those who were not. Exploratory analyses suggested that patients whose beta-blocker therapy was discontinued had a higher risk of adverse outcomes, particularly in the subset of patients randomized to milrinone. The data from this nonrandom comparison suggest that continuation of pre-existing beta-blocker therapy is not associated with an increased risk of adverse clinical events in patients admitted with worsening heart failure. These results also suggest that caution should be taken when withdrawing beta blockade in this population.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0002-9149(02)03104-1

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 8 references

Cited by

See all 80

Metadata

Authors
Gattis, W. A., O’Connor, C. M., Leimberger, J. D., Felker, G. M., Adams, K. F., & Gheorghiade, M.
Affiliations
  • Duke Medical Center (US)
  • University of North Carolina at Chapel Hill (US)
  • Northwestern University (US)
Corresponding author
Gattis, Wendy A
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2003-01
Volume
91
Issue
2
Pages
169-174
ISSN
0002-9149 (ISSN-L)
OpenAlex
W2086735139
Cited by
80
References
8
Citations by year
2026: 2 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 3
FWCI
3.51
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The American Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
beta-blockers, chronic heart failure, heart failure exacerbation, hospitalization, milrinone, beta-blocker discontinuation, clinical outcomes, adverse events
MeSH terms
Carvedilol, Adrenergic beta-Antagonists, Aged, Carbazoles, Cardiotonic Agents, Double-Blind Method, Drug Therapy, Combination, Female, Heart Failure, Heart Rate, Humans, Male, Metoprolol, Middle Aged, Propanolamines, Stroke Volume, Treatment Outcome, Milrinone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure. https://app.cochat.ai/papers/10.1016/s0002-9149(02)03104-1
The paper
Gattis, W. A., O’Connor, C. M., Leimberger, J. D., Felker, G. M., Adams, K. F., & Gheorghiade, M. (2003). Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure. The American Journal of Cardiology. https://doi.org/10.1016/s0002-9149(02)03104-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.